IT1303688B1 - Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo. - Google Patents

Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.

Info

Publication number
IT1303688B1
IT1303688B1 IT1998MI002350A ITMI982350A IT1303688B1 IT 1303688 B1 IT1303688 B1 IT 1303688B1 IT 1998MI002350 A IT1998MI002350 A IT 1998MI002350A IT MI982350 A ITMI982350 A IT MI982350A IT 1303688 B1 IT1303688 B1 IT 1303688B1
Authority
IT
Italy
Prior art keywords
acts
iii
complex
iron level
aromatic derivatives
Prior art date
Application number
IT1998MI002350A
Other languages
English (en)
Inventor
Napoli Guido Di
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1998MI002350A priority Critical patent/IT1303688B1/it
Application filed by Medidom Lab filed Critical Medidom Lab
Priority to ES99971418T priority patent/ES2189537T3/es
Priority to EP99971418A priority patent/EP1124814B1/en
Priority to SK556-2001A priority patent/SK286308B6/sk
Priority to DE69904635T priority patent/DE69904635T2/de
Priority to DK99971418T priority patent/DK1124814T3/da
Priority to US09/830,800 priority patent/US6455578B1/en
Priority to CA002348380A priority patent/CA2348380C/en
Priority to IL14281399A priority patent/IL142813A0/xx
Priority to BR9914863-3A priority patent/BR9914863A/pt
Priority to ARP990105492A priority patent/AR021037A1/es
Priority to PL347940A priority patent/PL198826B1/pl
Priority to SI9930227T priority patent/SI1124814T1/xx
Priority to CZ20011461A priority patent/CZ299542B6/cs
Priority to AU11573/00A priority patent/AU756726B2/en
Priority to PCT/EP1999/008222 priority patent/WO2000026205A1/en
Priority to AT99971418T priority patent/ATE229947T1/de
Priority to JP2000579593A priority patent/JP2002528539A/ja
Publication of ITMI982350A1 publication Critical patent/ITMI982350A1/it
Application granted granted Critical
Publication of IT1303688B1 publication Critical patent/IT1303688B1/it
Priority to IL142813A priority patent/IL142813A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT1998MI002350A 1998-11-02 1998-11-02 Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo. IT1303688B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT1998MI002350A IT1303688B1 (it) 1998-11-02 1998-11-02 Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.
SI9930227T SI1124814T1 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
SK556-2001A SK286308B6 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for use as normalising agents of iron level
DE69904635T DE69904635T2 (de) 1998-11-02 1999-10-29 Derivate von aromaten und deren eisen komplexe zur verwendung als regulierungsmittel des eisenspiegels
DK99971418T DK1124814T3 (da) 1998-11-02 1999-10-29 Aromatiske derivater og jernkomplekser deraf til anvendelse som normaliseringsmidler for jernspejlet
US09/830,800 US6455578B1 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level
CA002348380A CA2348380C (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
IL14281399A IL142813A0 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for use as normalising agents of the iron level
ES99971418T ES2189537T3 (es) 1998-11-02 1999-10-29 Derivados aromaticos y complejos de hierro de los mismos para su uso como agentes normalizantes del nivel de hierro.
ARP990105492A AR021037A1 (es) 1998-11-02 1999-10-29 Derivados aromaticos y sus relativos complejos de hierro aptos para el uso como agentes normalizantes del nivel de hierro en el organismo
PL347940A PL198826B1 (pl) 1998-11-02 1999-10-29 Pochodne aromatyczne, ich kompleksy z żelazem, kompozycje farmaceutyczne zawierające pochodne aromatyczne lub ich kompleksy z żelazem, zastosowanie pochodnych aromatycznych i ich kompleksów z żelazem
EP99971418A EP1124814B1 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
CZ20011461A CZ299542B6 (cs) 1998-11-02 1999-10-29 Aromatické deriváty a jejich komplexy se železem jako cinidla pro normalizaci hladiny železa
AU11573/00A AU756726B2 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
PCT/EP1999/008222 WO2000026205A1 (en) 1998-11-02 1999-10-29 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
AT99971418T ATE229947T1 (de) 1998-11-02 1999-10-29 Derivate von aromaten und deren eisen komplexe zur verwendung als regulierungsmittel des eisenspiegels
JP2000579593A JP2002528539A (ja) 1998-11-02 1999-10-29 鉄濃度の規格化剤として使用する芳香族誘導体とその鉄錯体
BR9914863-3A BR9914863A (pt) 1998-11-02 1999-10-29 Derivados aromáticos e complexos de ferro dos mesmos para uso como agentes de normalização do nìvel de ferro
IL142813A IL142813A (en) 1998-11-02 2001-04-25 Use of aromatic derivatives and iron complexes thereof in the preparation of pharmaceutical compositions for treating conditions to which an iron load is associated and pharmaceutical compositions comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002350A IT1303688B1 (it) 1998-11-02 1998-11-02 Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.

Publications (2)

Publication Number Publication Date
ITMI982350A1 ITMI982350A1 (it) 2000-05-02
IT1303688B1 true IT1303688B1 (it) 2001-02-23

Family

ID=11380986

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002350A IT1303688B1 (it) 1998-11-02 1998-11-02 Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.

Country Status (17)

Country Link
US (1) US6455578B1 (it)
EP (1) EP1124814B1 (it)
JP (1) JP2002528539A (it)
AR (1) AR021037A1 (it)
AT (1) ATE229947T1 (it)
AU (1) AU756726B2 (it)
BR (1) BR9914863A (it)
CA (1) CA2348380C (it)
CZ (1) CZ299542B6 (it)
DE (1) DE69904635T2 (it)
DK (1) DK1124814T3 (it)
ES (1) ES2189537T3 (it)
IL (2) IL142813A0 (it)
IT (1) IT1303688B1 (it)
PL (1) PL198826B1 (it)
SK (1) SK286308B6 (it)
WO (1) WO2000026205A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009531379A (ja) * 2006-03-29 2009-09-03 ビーエーエスエフ ソシエタス・ヨーロピア 鉄代謝機能障害を治療するためのストロビルリンの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122200A (en) * 1974-11-20 1978-10-24 Lipha, Lyonnaise Industrielle Pharmaceutique 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof
ATE14579T1 (de) * 1979-03-20 1985-08-15 Fisons Plc Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
EP0346279A1 (de) * 1988-06-06 1989-12-13 Ciba-Geigy Ag Propan-1,3-dionderivate und deren Verwendung als Stabilisatoren für chlorhaltige Polymerisate

Also Published As

Publication number Publication date
AU756726B2 (en) 2003-01-23
US6455578B1 (en) 2002-09-24
DE69904635T2 (de) 2003-10-02
IL142813A0 (en) 2002-03-10
ITMI982350A1 (it) 2000-05-02
JP2002528539A (ja) 2002-09-03
AR021037A1 (es) 2002-06-12
CZ20011461A3 (cs) 2001-08-15
ATE229947T1 (de) 2003-01-15
DK1124814T3 (da) 2003-04-14
DE69904635D1 (de) 2003-01-30
SK286308B6 (en) 2008-07-07
CA2348380C (en) 2009-02-17
PL347940A1 (en) 2002-04-22
IL142813A (en) 2006-12-10
PL198826B1 (pl) 2008-07-31
ES2189537T3 (es) 2003-07-01
WO2000026205A1 (en) 2000-05-11
BR9914863A (pt) 2001-07-03
SK5562001A3 (en) 2001-09-11
EP1124814B1 (en) 2002-12-18
AU1157300A (en) 2000-05-22
EP1124814A1 (en) 2001-08-22
CA2348380A1 (en) 2000-05-11
CZ299542B6 (cs) 2008-08-27

Similar Documents

Publication Publication Date Title
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
ITMI950493A0 (it) Frazioni polifenoliche di te' loro uso e formulazioni che le contengono
ATE246514T1 (de) Paclitaxel enthaltende arzneimittel
NO996269D0 (no) Quinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
WO2000038665A3 (en) Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
BG105256A (en) Muscarinic agonists and antagonists
HUP0100048A3 (en) Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
FI934565A (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
NO992604L (no) Oppbygningsundertrykkende midler, blandinger inneholdende slike midler og anvendelse derav i polymeriseringsprosessen
IT1303688B1 (it) Derivati aromatici e relativi complessi di fe(iii) atti all'usocome agenti normalizzanti del livello di ferro nell'organismo.
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
MX9102021A (es) Composiciones detergentes o blanqueadoras granuladas que contienen blanqueador de midoperoxiacido y perfume.
BG104914A (en) Paroxetine maleate
DE69227515D1 (de) Schaum stabilisierende agentien und bittermacher aus hopfen
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
IT1254452B (it) N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
ATE128815T1 (de) Verbesserungen in bezug auf die behandlung von tee.
Lee et al. The Effects of Stocking Density in Transit on Blood Profile and Pork Quality
Lee et al. Seasonal Distribution of Enterovirures in Source Water
Lee The pprosppects of FPD Market and Technology
ZA9810815B (en) Use of lectin preparations in the treatment of bladder carcinoma
IT1290190B1 (it) Uso dell'incenso in campo agronomico.